Dorsey Wright & Associates Charles River Laboratories International, Inc. Transaction History

Dorsey Wright & Associates

  • $408 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022
SELL
$255.51 - $362.11 $4.61 Million - $6.53 Million
-18,033 Closed
0 $0
Q4 2021

Jan 27, 2022
BUY
$351.38 - $448.68 $169,013 - $215,815
481 Added 2.74%
18,033 $6.79 Million
Q3 2021

Oct 26, 2021
BUY
$372.64 - $458.3 $2.78 Million - $3.42 Million
7,462 Added 73.95%
17,552 $7.24 Million
Q2 2021

Jul 23, 2021
BUY
$294.17 - $371.65 $2.97 Million - $3.75 Million
10,090 New
10,090 $3.73 Million

Others Institutions Holding CRL

# of Institutions
698
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Dorsey Wright & Associates Portfolio

Follow Dorsey Wright & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Dorsey Wright & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email